FDA Adverse Event Injury Summary report: N

JUVEDERM ULTRA PLUS

MDR report key: 897301 · Received March 9, 2007

Report

Report Number
3005113652-2007-00004
Event Type
Injury
Date Received
March 9, 2007
Date of Event
January 3, 2007
Report Date
February 8, 2007
Manufacturer
CORNEAL
Product Code
LMH
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
CA, US
Reporter Occupation
OTHER

Narratives

Additional Manufacturer Narrative · 1

MEDWATCH SENT TO FDA ON 09/MAR/07. PLEASE NOTE CORNEAL INDUSTRIES IS AWAITING ASSIGNMENT OF FDA REGISTRATION. THE LOT NUMBER OF THE PRODUCT WAS PROVIDED BY THE PHYSICIAN'S OFFICE ON 09/MAR/07. A DEVICE HISTORY REVIEW IS NOW ABLE TO BE REQUESTED OF CORNEAL AND A SUPPLEMENTAL MEDWATCH WILL BE SUBMITTED WHEN THE RESULTS BECOME AVAILABLE.

Description of Event or Problem · 1

THE PATIENT REPORTED THAT IMMEDIATELY FOLLOWING THE JUVEDERM INJECTIONS IN THE LOWER EYE LID AREA, IT BEGAN SWELLING EXCESSIVELY. ICE PACKS WERE APPLIED TO THE AREA WITH NO SUCCESS. THREE WEEKS LATER, THE PATIENT APPLIED PREPARATION H TO THE INFLAMED ARA WITH HOPES THAT A VASOCONSTRICTING AGENT WOULD HELP WITH THE SWELLING. THE TREATING PHYSICIAN PRESCRIBED A MEDROL DOSEPAK. THE PATIENT FEELS THAT NEITHER THE PREPARATION H NOR THE MEDROL DOSE PACK HELP WITH THE SWELLING. THE PATIENT NOTES THAT THE SWELLING HAS IMPROVED GRADUALLY OVER TIME BUT THE AREA HAS NOT FULLY RESOLVED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 JUVEDERM ULTRA PLUS JUVEDERM LMH CORNEAL HV30229483

Patients

Seq Age Sex Outcome Treatment
1 NI YR Required Intervention PROZAC| MULTIVITAMIN